Shares of HIMS experienced a dramatic slump today following the unexpected cancellation of its partnership with pharmaceutical giant HIMS and Novo Nordisk Split Novo Nordisk. Investors interpreted negatively to the news, sending the company's stock price plummeting by nearly fifteen percent. The reason for the breakdown of the partnership remains u